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initial hemogram, LFT & KFT and, ABG were suggestive of Severe
metabolic acidosis with hypokalemia with TLC of 30,000.
Provisional diagnosis was made on the lines of Acute Myocarditis
or Alleged poisoning.
We got to the basics and tried to illicit history from parents.
Her father was suffering from COPD with coronary artery disease
and PTCA 4 yr back. Her father was on T. Ecosprin-AV, T. Ramipril
5 mg, T. Tideplus 10/25, T. Dilzem 60 mg, Inhalers and bronchodi-
lators. Her father fainted to see that the day before he bought
wholemedicines for amonth, and out of 60 tablets of Diltiazem, he
was left only with 10.
She had made a suicidal attempt with 3 grams of Diltiazem.
In addition to the standard resuscitativemeasures, the patient was
treated with 30 ml of 10% Calcium Gluconate over 5 min followed
by an infusion of 10 ml/hr of calcium gluconate. 10 mg of Glucagon
was administered intravenously followed by an infusion at 3 mg/
hr. As our surprise, after 1 hour of starting Glucagon infusion, her
heart rate shoots up to 100/min and blood pressure to 90–
95 mmHg.With these measures, the patient started showing signs
of improvement in her hemodynamics, with Blood Sugar reading
of 498. She was started on 40 units of insulin hourly after giving 60
units stat., ABG showed some improvement with pH of 7.2 and
potassium 2.8,and was continued on IV KCl also. Over the next
48 hrs she showed gradual improvement in her clinical condition.
Inotropes, Calcium and Glucagon infusions were ceased after 72 h
of admission. On day four, she was extubed andwas discharged on
seventh day.
Discussion: Calcium channel blockers (CCB) are used extensively
for treatment of hypertension, angina pectoris, tachyarrhythmias
and migraine prophylaxis. Reports of serious CCB toxicity are rare
as it results in delayed and prolonged toxicity. Treatment of CCB
overdose is difﬁcult and refractory with a high mortality and with
fatal outcome.
There are 3 main classes of CCBs: phenylalkalines, benzothiaze-
pines, and dihydropyridines, each with different afﬁnity for cal-
cium channels and, especially at toxic concentrations; this is
associated with a diversity of clinical consequences. The diagnosis
is frequently missed in the early stage of hospital admission
because of varied clinical manifestations. The pathophysiologic
basis of the hemodynamic consequences of CCB intoxication is the
low intracellular calcium concentration leading to depression of
cardiac function and dilatation of smooth muscle cells (vasodila-
tation and ileus). The present patient had a long-lasting, severe
cardiovascular shock condition, disturbing the autoregulation of
the brain leading to cerebral hypoperfusion. Treatment for CCB
overdose suggested in the literature is often mainly symptomatic
and supportive. The use of intravenous ﬂuids, atropine, catecho-
lamines, glucagon, insulin phosphodiesterase (PDE) inhibitors,
electrical pacing and mechanical support by intraortic balloon
pumping, and extracorporeal circulation have also been reported.
Implications to the clinical practice: In diagnostic dilemmas,
proper history taking even to the extent of personal history of
1st degree relatives is important, to come to a conclusion. CCBs
toxicity as per suicidal purpose is unknown and usually lethal if
not intervened timely, and its diagnosis can't be established with-
out high degree of suspicion and meticulous history taking.
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Introduction: Pulmonary embolism is a common problem specially
in postoperative and immobilized patients. High index of clinical
suspicion in postoperative patients with unexplained shortness of
breathing should be evaluated for possible pulmonary embolism
Case summary: A middle aged female presented with sudden
onset of unexplained shortness of breathing, hypotension, tachyp-
nea, tachycardia on 2nd post-operative day after laproscopic cho-
licystectomy. For which surgeon reopen the abdomen to rule-out
any active bleeding or clot but nothing found. The 2nd post-op day
D-DIMER within normal range. Bedside peripheral venous Doppler
study found normal. On 3rd post-op day they call to cardiologist to
see the case. When we reach to ICU patient on ventilatory support
with spo2 82%, Heart rate 130/min, SBP 80 mm of Hg on inotropes.
ECG shows sinus tachycardia. Bed side 2D-Echo done which
showed massively dilated and a kinetic RV, Pulmonary artery
pressure 70 mm of Hg, moderate tricuspid regurgitation but no
clot seen in RA, RV and Pulmonary artery. Chest X-ray showing
right basal region wedge shaped homogeneous opacity. 3rd post-
op day D-DIMER >8000. Cardiac enzymes CPKMB, Troponin-I, and
BNP were elevated signiﬁcantly. Pt cannot be shifted for CT-Pul-
monary angiography because of dearranged renal function and
detoriated clinical condition. We consider the case of pulmonary
embolism and started thrombolysis with streptokinase infusion in
view of high suspicion of pulmonary embolism in critically ill and
deteriorating patient with explained risk of bleeding in post-op
patient. 24 hr after starting of streptokinase review 2D-Echo done
which showed that dilation of RV become less from previous day
echo and PA pressure fall down to 45 mm of Hg. Wemake decision
to continue streptokinase for three days. During these three day
heart rate settle down to normal, patient wean of from ventilator
support and BP comes to 100/60 mm of Hg without inotropes. After
completion of three day infusion 2D-echo done which showed
normal dimension and RV systolic function with trace TR and
normal pulmonary artery pressure. Chest X-ray become normal
with clearance of opacity. Cardiac enzymes and BNP settled down
to normal. Patient discharged with stable condition with antic-
oagulation.
Conclusion: High index of clinical suspicion of pulmonary embo-
lism in post-operative patients can save life with use of extended
regimen of thrombolysis with Streptokinase.
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Background: Contrast induced nephropathy (CIN) is common after
percutaneous coronary intervention (PCI). Serum Cystatin C (CyC)
is a reliable marker than serum creatinine (Cr) in evaluating the
estimated glomerular ﬁltration rate (eGFR) in patients with acute
renal failure during the ﬁrst 24–48 h.
Aims and objectives: To investigate (1) if CyC and/or eGFRCyC are
superior to Cr and/or eGFRCr for early detection of periprocedural
CIN. (2) If the combined Cr-CyC equation performs better that
equations based on either of these markers alone for early detec-
tion of CIN.
Methods: It was a single centre prospective observational study.
Total 253 adult patients with an indication for coronary interven-
tion were enrolled. CIN was deﬁned as an increase in Cr of ≥25% or
≥0.5 mg/dl above the baseline value within 48 hours after the
contrastmedium (CM) administration, in absence of another cause
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to explain the rise in Cr and ≥10% rise in serum cystatin levels from
baseline at 24 h. Cr will be assessed at baseline and at 24, 48 and
72 h and CyC will be measured at baseline and at 24 h.
Results: After 48 hrs of CM exposure, Cr increase ≥0.5 mg/dL
occurred in 29 patients (11.3%) whereas increase in CyC ≥10% at
24 hrs after CM exposure occurred in 66 patients (26.08%). The
difference in mean Cr and baseline, 24 hrs and 48 hrs after CM
exposure was not statistically signiﬁcant whereas that between
CyC at baseline and 24 h after CM exposure was signiﬁcant. CyC
detected CIN 24 hrs earlier as compared to Cr. Similarly the dif-
ference between GFR calculated by Cr equation was not statisti-
cally signiﬁcant between pre and post CM exposure but the
difference was signiﬁcant when GFR was calculated using the
combined equation. The risk of CIN was higher in patients with
pre-existing CKD, diabetes, advanced age, haemodynamic instabil-
ity, heart failure (LVEF < 40%), patients with ACS and higher con-
trast volumes.
Conclusions: The assessment of CyC at 24 hours after CM exposure
allows an early diagnosis of CIN. Also CyC equation and the
combined equation (Cr + CyC) for measurement of GFR accurately
identiﬁed the patients with CIN even at 24 hrs after CM exposure,
in contrast to Creatinine which took 48-72 hrs. Hence the manage-
ment strategies for CIN can be started earlier by 24-48 hrs when
CyC is used as a marker for CIN which would improve long term
outcomes.
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Background: Pulmonary embolism (PE) is one of themajor cause of
cardiovascular mortality. High index of suspicion is necessary for
diagnosis. PE likelihood scoring is a useful clinical tool for risk
stratiﬁcation and management. This was a prospective registry to
study the clinical features, clinical likelihood scoring, risk strati-
ﬁcation and management of PE.
Methods: Consecutive cases hospitalized over a period of 3 years
were studied. Revised Geneva score was applied to all cases of
suspected pulmonary embolism. Most cases had PE conﬁrmed by
CT pulmonary angiography. Risk stratiﬁcation (Pulmonary Embo-
lism Severity Index from 2015) was used to guide the treatment
strategy.
Results: There were 44 patients of pulmonary embolism, 26 being
male. The mean age for male patients was 43.8 years and for
females 55.4 years. Among 44 patients, 11 (25.0%) patients had
surgery or immobilisation in the past 30 days, 15 (34.09%) patients
had DVT. 4 (9.09%) patients had diabetes, 3 (6.81%) had hyperten-
sion. 6 (13.6%) patients were smokers. 37 (84.0%) patients had
breathlessness. ECG revealed sinus tachycardia in 34 (77.2%). Echo-
cardiogram showed dilated right atrium (RA) & right ventricle (RV)
in 32 (72.7%) patients and RV dysfunction in 10 (22.7%) patients.
The mean modiﬁed Geneva score was 8.18 for males and 9.7 for
female. CT pulmonary angiography was done in 33 patients which
conﬁrmed PE in 32 cases. Risk stratiﬁcation according to expected
pulmonary embolism-related early mortality rate stratiﬁed 11
(25.0%) patients in high risk group, 27 (61.3%) patients in inter-
mediate risk group & 6 (13.6%) patients in low risk group. 27 (61.3%)
patients were thrombolysed with tenecteplase & 3 (6.8%) with
reteplase. 1 patient had emergency surgical thrombo-endartect-
omy, recovering fully after an eventful post-operative period. Post-
treatment most patients showed improvement.
Conclusion: Modiﬁed Geneva score along with imaging investiga-
tions helped in establishing diagnosis. Thrombolytic therapy in
high risk cases and selected intermediate risk cases was safe and
effective.
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Background: It is well proven that sildenaﬁl improves pulmonary
hemodynamics and exercise capacity in patients with primary
pulmonary hypertension. However, the drug armamentarium
for secondary pulmonary hypertension is limited. Sildenaﬁl may
also be helpful in this subgroup. Certain studies have shown
promising results but none of the magnitude to promulgate new
recommendations.
Methods: In this double-blind, placebo-controlled study, we ran-
domly assigned 106 patients with symptomatic secondary PAH
(idiopathic DCMP, heart failure with preserved EF, COPD, and other
lung parenchymal disease, valvular heart disease) to placebo or
sildenaﬁl (53 in each group). Sildenaﬁl was given orally 25 mg TID
for 6 weeks. The primary end point was the change from baseline
to week 6 in the distance walked in 6 minutes. We also assessed
clinical improvement (improvement in 6 minute walk test, and
NYHA functional class, change in Borg dyspnoea index) and
change in hemodynamic parameters (PASP, LVEF).
Results: Of the 106 patients, included secondary PAH was due to
COPD in 21 (19.8%), valvular heart disease in 53 (50%), heart failure
with preserved EF in 16 (15%), idiopathic DCMP in 11 (10.2%) and
other lung parenchymal diseases in 5 (5%). The mean increase in
the distance walked after 6 weeks of therapy was 54 min sildenaﬁl
group and 13 m in placebo group p = 0.04. In the sildenaﬁl group
signiﬁcantly greater number of patients improved by at least one
functional class (23% vs 11%, p = 0.003). The mean NYHA class at 6
weeks was 2.0  0.2 in the sildenaﬁl group versus 2.8  0.4 in the
placebo group, p = 0.02. The mean PASP signiﬁcantly decreased in
the sildenaﬁl group at 6 weeks (48  6 mmHg), compared to pla-
cebo (58  6 mmHg), p = 0.02. LVEF was higher in the sildenaﬁl
group, 60  10% versus 55  10% in the placebo group, but did
not reach statistically signiﬁcant difference.
Conclusion: Sildenaﬁl improves exercise capacity, functional class,
and hemodynamics in patients with PAH. PDE-5 inhibition may
represent an important therapy for patients with secondary PAHif,
the beneﬁts observed in our study are conﬁrmed in larger clinical
trials.
Use of dabigatran versus warfarin in
patients of atrial fibrillation at Asian
heart hospital – An institutional based
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Background: Atrial ﬁbrillation increases the risks of stroke and
death. Although warfarin reduces the risks of stroke and death, it
increases the risk of hemorrhage along with its other drawbacks.
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